The trajectory of companies tied to Sildenafil's legacy presents a challenging investment picture . While the initial boom generated substantial gains, generic copies have significantly impacted market share . Investing in connected pharmaceutical businesses now requires a discerning assessment of patent protection , evolving healthcare changes, an